- Home
- ACRV vs AIIO Comparison
ACRV vs AIIO Comparison
Compare ACRV & AIIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACRV | AIIO |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Manufacturing |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.6M | 106.6M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACRV | AIIO |
|---|---|---|
| Price | $1.64 | $0.16 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | 898.4K | ★ 5.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $805.34 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $0.11 |
| 52 Week High | $5.68 | $2.82 |
Technical Indicators
Market Signals| Indicator | ACRV | AIIO |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 42.10 |
| Support Level | $1.51 | $0.11 |
| Resistance Level | $2.47 | $0.34 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 50.56 | 69.55 |
Price Performance
Historical ComparisonAbout ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About AIIO Robo.ai Inc. Class B Ordinary Shares
Robo.ai Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world. Geographically, the company operates in The United States, The United Arab Emirates, Mainland China.